In a first of its kind an ANZ study reveals the relative risk for local patients obtaining ALCL following breast implants and how the risk varies with implant type.

Magnusson M, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK. The

Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in

Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast

Implants. Plast Reconstr Surg. 2019 May;143(5):1285-1292